Showing results (111-120 of 231) with videos related to

Sort By:
Pageof 24
Cancer Causes & Control : CCC|June 11, 2014
Serum transforming growth factor-β1 and risk of pancreatic cancer in three prospective cohort studiesEric J Jacobs, Christina C Newton, Debra T Silverman, et al.
International Journal of Cancer|December 30, 2003
Serum concentrations of IGF-I, IGFBP-3 and c-peptide and risk of hyperplasia and cancer of the breast in postmenopausal womenCatherine Schairer, Deirdre Hill, Susan R Sturgeon, et al.
Cancer Causes & Control : CCC|March 16, 2012
Maternal and cord steroid sex hormones, angiogenic factors, and insulin-like growth factor axis in African-American preeclamptic and uncomplicated pregnanciesJessica M Faupel-Badger, Yuping Wang, Anne Cathrine Staff, et al.
Cancer Causes & Control : CCC|September 21, 2014
Associations between time spent sitting and cancer-related biomarkers in postmenopausal women: an exploration of effect modifiersRaheem J Paxton, Su Yon Jung, Mara Z Vitolins, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 18, 2008
Plasma insulin-like growth factors, insulin-like binding protein-3, and outcome in metastatic colorectal cancer: results from intergroup trial N9741Charles S Fuchs, Richard M Goldberg, Daniel J Sargent, et al.
Carcinogenesis|July 27, 2021
Blood biomarkers reflect the effects of obesity and inflammation on the human breast transcriptomeByuri Angela Cho, Neil M Iyengar, Xi Kathy Zhou, et al.
The Prostate|September 12, 2008
Insulin receptor expression by human prostate cancersMichael E Cox, Martin E Gleave, Mahvash Zakikhani, et al.
Endocrine-Related Cancer|September 28, 2011
IGF1/insulin receptor kinase inhibition by BMS-536924 is better tolerated than alloxan-induced hypoinsulinemia and more effective than metformin in the treatment of experimental insulin-responsive breast cancerCarly Jade Dool, Haider Mashhedi, Mahvash Zakikhani, et al.
Clinical Genitourinary Cancer|January 29, 2019
Impact of Addition of Metformin to Abiraterone in Metastatic Castration-Resistant Prostate Cancer Patients With Disease Progressing While Receiving Abiraterone Treatment (MetAb-Pro): Phase 2 Pilot StudyMichael Mark, Dirk Klingbiel, Ulrich Mey, et al.
Breast Cancer Research : BCR|October 18, 2008
Redefining prognostic factors for breast cancer: YB-1 is a stronger predictor of relapse and disease-specific survival than estrogen receptor or HER-2 across all tumor subtypesGolareh Habibi, Samuel Leung, Jennifer H Law, et al.
Pageof 24